News
Yosprala Launched for Secondary Prevention of CV Events in Ulcer-Risk Patients
Yosprala combines aspirin, an antiplatelet, and omeprazole, a proton pump inhibitor.
Your search for proton pump inhibitor returned 31 results
News
Proton Pump Inhibitor Use May Up Death Risk
The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).
News
Do PPIs Protect Against Dysplasia, Cancer in Barrett’s Esophagus?
In patients with Barrett's esophagus, use of proton pump inhibitors (PPIs) did not lead to dysplasia- or cancer-protective effects.
News
FDA Expands Dexilant Use for Younger GERD Patients
Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for patients aged 12-17 years with gastroesophageal reflux disease (GERD).
IDWEEK 2016 - Adult Infectious Diseases
PPIs and Gastroenteritis Hospitalization: What’s the Risk?
Use of proton pump inhibitors (PPIs) was tied to a higher risk of infectious gastroenteritis hospitalization with increasing risk among increasing doses.
News
Some Antacids Linked to Heart Attack Risk
Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16 to 21 percent compared to those who don't use commonly prescribed antacids, a large study has found.
News
Myopathy: Another Side Effect of PPIs?
Limited research published in Annals of Pharmacotherapy suggests that use of proton pump inhibitors (PPI) is associated with myopathy-like symptoms without long-term effects after discontinuation.
AASLD 2016
Long-term PPI Use Reduces Bleeding-Related Mortality in Cirrhosis Patients
Long-term use of proton pump inhibitors (PPIs) reduces bleeding-related mortality in patients with cirrhosis and variceal bleeding, a prospective study reported at The Liver Meeting® 2016.
Generics News
Dr. Reddy’s Launches Generic Nexium
Dr. Reddy's Laboratories announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium Delayed-Release Capsules.
Generics News
Teva Launches Generic Nexium
Teva announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium.
